Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution
Filter News
Show All Results
News By Country
News By Industry
Biotech Remove
News By Subject


November 2014
Su Sa Fr Th We Tu Mo
23 22 21 20 19 18 17

Biotech Press Releases

  + XML/RSS  



173 views, By NAPSRx
Hysingla ER is a once-daily opioid analgesic formulated with abuse-deterrent properties.

702 views, By SMi Group
14th annual conference on Advances & Progress in Drug Design, 16th and 17th February 2015, Marriott Regents Park Hotel, London UK

81 views, By NAPSRx
Sanofi and Regeneron’s investigational therapy, Dupilumab has received the Breakthrough Therapy Designation from the U.S.

170 views, By Remi Elektrotechnik Ltd
Launch of Dry Bath, Visi Coolers, Ice Flaker, Micro Centrifuges and host of next generation products for laboratory, research and pharmaceutical industry.

372 views, By iGEM
Over 2300 university students competed in the 10th annual international synthetic biology competition held on October 30 - November 3, 2014 in Boston, MA

476 views, By Precision Building Construction, LLC
Quality and efficacy are paramount as technologies evolve in sophistication, creating additional demands. PBC has completed the redesign and installation of a high-performance air handling system for Olympia, resulting in improved operational efficiency.

138 views, By NAPSRx
Pfizer and Merck KGaA have announced plans to enter into an agreement to jointly develop and commercialize the investigational anti-PD-L1 antibody MSB0010718C developed by Merck KGaA to treat multiple forms of cancer.

427 views, By Leaders in Pharmaceutical Business Intelligence
Over 500,000 Unique Site Visits reached by pharmaceuticalintelligence.com Reported today by Leaders in Pharmaceutical Business Intelligence (LBPI)

208 views, By Therigiy
Today Therigy announced that Jon Hamrick, Executive Vice President, Biotech & Specialty Services, will be speaking at CBI’s 10th Life Sciences Trade & Channel Strategies conference on Wednesday, December 10, 2014, at 1:30 p.m.

165 views, By Lacerta Bio
Lacerta Bio to merge with an international Life Science advisory firm, Ventac Partners, to strengthen their position in USA.

135 views, By NAPSRx
Genzyme’s MS therapy, Lemtrada (alemtuzumab) has been approved by the U.S. Food and Drug Administration to treat patients with relapsing forms of multiple sclerosis (MS).

379 views, By Molekule Consulting, Inc.
Molekule consulting, Inc. to sponsor & exhibit at the 2015 Pharma CI Europe Conference & Exhibition. Molekule President, David Alderman, to speak on key competitive intelligence topic

182 views, By Viewpoint Laboratories, LLC
Viewpoint Laboratories, LLC, announced today their newest gel documentation product, the ZIG-gel, combining the imaging power of an 18 MP, 10x optical zoom camera with the convenience of Wi-Fi control and capture from the user's own mobile device.

175 views, By NAPSRx
The approval of Pfizer's Trumenba represents the first vaccine licensed in the United States to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B in individuals 10 through 25 years of age.

1958 views, By MoBiTec GmbH
MoBiTec GmbH expands its product line of tools for gene expression in Bacillus megaterium with the new expression host YYBm1. Strain YYBm1 is unable to utilize the expression system's inductor molecule xylose as carbon source.

187 views, By Therigy, LLC
Therigy is pleased to announce the release of a new module, Respiratory Syncytial Virus (RSV), within its specialty therapy management application TherigySTM.

260 views, By Oviya MedSafe
The need for pharmacovigilance compliance in RoW assumes more significance as the demand for harmonization and implementation of regulations is growing across all markets.

272 views, By NAMSR
Researchers are developing a novel prochlorperazine nasal spray formulation as a potential new treatment for migraines.

375 views, By NAPSRx
The U.S. Food and Drug Administration (FDA) has approved Eli Lilly’s CYRAMZA® (ramucirumab) combined with paclitaxel (a type of chemotherapy) to treat individuals with a progressive form of  metastatic gastric (stomach) or gastroesophageal...

260 views, By AhR Pharmaceuticals, Inc.
AhR Pharmaceuticals Announces the Issuance of its Japan Patent on ITE for Cancer Intervention and Possible Eradication by the Japan Patent Office (JPO)

All Press Releases

25 views, By Anviz Global
Anviz Global is looking to deepen links in the South America market. Recent cooperation on projects in Paraguay between Anviz and security integration company, Megapar Ingenieria SA, highlight the beginning of this strategy.

173 views, By NAPSRx
Hysingla ER is a once-daily opioid analgesic formulated with abuse-deterrent properties.

702 views, By SMi Group
14th annual conference on Advances & Progress in Drug Design, 16th and 17th February 2015, Marriott Regents Park Hotel, London UK

118 views, By IQ4I Research & Consultancy
IQ4I estimates The Global API Market to reach $173.5 billion by 2020. First report to cover market revenue ($) for all segments, by synthesis type (Synthetic, Biotech, HPAPI), Business type (Captive and Merchant) and more than 11 therapeutic areas

81 views, By NAPSRx
Sanofi and Regeneron’s investigational therapy, Dupilumab has received the Breakthrough Therapy Designation from the U.S.

170 views, By Remi Elektrotechnik Ltd
Launch of Dry Bath, Visi Coolers, Ice Flaker, Micro Centrifuges and host of next generation products for laboratory, research and pharmaceutical industry.

372 views, By iGEM
Over 2300 university students competed in the 10th annual international synthetic biology competition held on October 30 - November 3, 2014 in Boston, MA

98 views, By Shenzhen Power Batteries
To maintain their leading status, SPB has invested extensively in Research and Development with teams of published chemical engineers, who have generated more than 40 national technology patents for SPB in advanced cell design.

476 views, By Precision Building Construction, LLC
Quality and efficacy are paramount as technologies evolve in sophistication, creating additional demands. PBC has completed the redesign and installation of a high-performance air handling system for Olympia, resulting in improved operational efficiency.

79 views, By i-calQ, LLC
The first smartphone-based quantitative point-of-care diagnostic platform with integrated decision support. Turn any smartphone into a portable laboratory and medical specialist.

138 views, By NAPSRx
Pfizer and Merck KGaA have announced plans to enter into an agreement to jointly develop and commercialize the investigational anti-PD-L1 antibody MSB0010718C developed by Merck KGaA to treat multiple forms of cancer.

427 views, By Leaders in Pharmaceutical Business Intelligence
Over 500,000 Unique Site Visits reached by pharmaceuticalintelligence.com Reported today by Leaders in Pharmaceutical Business Intelligence (LBPI)

105 views, By NewAge Industries-AdvantaPure
A United States patent has been awarded to AdvantaPass, a clean room wall pass-through system designed to transfer fluids between clean rooms and maintain room isolation during pharmaceutical and biopharmaceutical production.

208 views, By Therigiy
Today Therigy announced that Jon Hamrick, Executive Vice President, Biotech & Specialty Services, will be speaking at CBI’s 10th Life Sciences Trade & Channel Strategies conference on Wednesday, December 10, 2014, at 1:30 p.m.

165 views, By Lacerta Bio
Lacerta Bio to merge with an international Life Science advisory firm, Ventac Partners, to strengthen their position in USA.

135 views, By NAPSRx
Genzyme’s MS therapy, Lemtrada (alemtuzumab) has been approved by the U.S. Food and Drug Administration to treat patients with relapsing forms of multiple sclerosis (MS).

379 views, By Molekule Consulting, Inc.
Molekule consulting, Inc. to sponsor & exhibit at the 2015 Pharma CI Europe Conference & Exhibition. Molekule President, David Alderman, to speak on key competitive intelligence topic

82 views, By Creative Biolabs
Antibody has a considerably long history and plays an absolutely essential role through the development process of medicine and biotechnology.

142 views, By Pharma Market Research Conference
The Pharma Market Research Conference is the premier gathering of senior-level pharmaceutical, biotechnology, medical device, and diagnostics executives in market research.

357 views, By Anviz Global
Anviz Global has teamed up with Megapar Ingenieria SA to improve security at the newly renovated airport in the Paraguayan capital, Asuncion. Megapar installed Anviz-designed biometric devices throughout Silvio Pettirossi International airport.

104 views, By PharmSource
Leader in contract bio/pharma industry intelligence predicts ongoing in-house manufacture

110 views, By Integrated Biometrics
National Institute of Standards and Technology, EU-LISA, CARTES SECURE CONNEXIONS Events Feature World-Class Fingerprint Tech Insight

175 views, By Bharat Book Bureau
Bharatbook.com announces Additional 30% Discount on PCR Technologies. PCR has evolved to become one of the fundamental technology platforms in life sciences sector, included Diagnostics & Biotechnology. Hurry Up!!! (Offer valid till 31st Dec.2014)

182 views, By Viewpoint Laboratories, LLC
Viewpoint Laboratories, LLC, announced today their newest gel documentation product, the ZIG-gel, combining the imaging power of an 18 MP, 10x optical zoom camera with the convenience of Wi-Fi control and capture from the user's own mobile device.

155 views, By Biotage GB Limited
Biotage announces the launch of Biotage® SNAP ULTRA C18 - a range of high performance, reversed phase flash purification cartridges and samplets.

175 views, By NAPSRx
The approval of Pfizer's Trumenba represents the first vaccine licensed in the United States to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B in individuals 10 through 25 years of age.

117 views, By Venture Planning Group
The pharma companies have a significant opportunity for Ebola virus infection drugs and vaccines, expected to be priced at a premium.

176 views, By American Conference Institute
New to this year’s Drug and Medical Device Litigation conference agenda - prepare for increased off-label, consumer fraud, and false claims enforcement actions stemming from drug and med device products liability.

1958 views, By MoBiTec GmbH
MoBiTec GmbH expands its product line of tools for gene expression in Bacillus megaterium with the new expression host YYBm1. Strain YYBm1 is unable to utilize the expression system's inductor molecule xylose as carbon source.

187 views, By Therigy, LLC
Therigy is pleased to announce the release of a new module, Respiratory Syncytial Virus (RSV), within its specialty therapy management application TherigySTM.

260 views, By Oviya MedSafe
The need for pharmacovigilance compliance in RoW assumes more significance as the demand for harmonization and implementation of regulations is growing across all markets.

272 views, By NAMSR
Researchers are developing a novel prochlorperazine nasal spray formulation as a potential new treatment for migraines.

375 views, By NAPSRx
The U.S. Food and Drug Administration (FDA) has approved Eli Lilly’s CYRAMZA® (ramucirumab) combined with paclitaxel (a type of chemotherapy) to treat individuals with a progressive form of  metastatic gastric (stomach) or gastroesophageal...

131 views, By Metrics Inc.
Dr. Anshul Gupte, associate director for pharmaceutical development, has evaluated the correlation between the type of binder used in the formulation on the roller compaction processing parameters and subsequent tablet properties.

260 views, By AhR Pharmaceuticals, Inc.
AhR Pharmaceuticals Announces the Issuance of its Japan Patent on ITE for Cancer Intervention and Possible Eradication by the Japan Patent Office (JPO)

201 views, By Vax-Immune, LLC
This technology enables the rapid diagnosis, treatment, and prevention of Ureaplasma infection. The first steps towards commercialization focuses on development of the rapid diagnostic at the point of care and treatment for preterm infants.

313 views, By IQ4I Research & Consultancy
IQ4I Estimates The global NGS market to reach $4.89 billion by 2020. The first report to cover both Market size ($$) and Market Volume (Number of platforms, Number of research labs/hospitals/biotech and Number of Samples per technology)

231 views, By NAPSRx
Astellas will collaborate with Proteostasis Therapeutics, Inc to develop novel therapeutic contenders that modulate Unfolded Protein Response (UPR) utilizing Proteostasis’ proprietary “Disease Relevant Translation” (DRT™) and “Proteostasis...

204 views, By SMi Group
Pharmaceutical Microbiology, 21st & 22nd January 2015, Marriott Regents Park Hotel, London UK

99 views, By Metrics Inc.
In a poster presentation at AAPS, Dr. Brad Gold at Metrics Contract Services demonstrates that two propellants commonly used in prescription inhalers are exhaled primarily unchanged

137 views, By Q1 Productions
Interactive Sessions to Address Prevention of Counterfeit Products, FDA Expectations, Future of Sustainability Trends

905 views, By World Patent Marketing
World Patent Marketing announces on Election Day that it is planning a massive expansion in 2015 that will include the addition of 200 new full-time jobs.

118 views, By Creative Biolabs
Lab-grown tissues could one day provide new treatments for injuries and damage to the joints, including articular cartilage, tendons and ligaments.

412 views, By NAPSRx
According to a new study published in the journal Neuropharmacology conducted by research academics at Lancaster University, certain type 2 diabetes drugs on the market have produced neuroprotective effects in a mouse model of Alzheimer's disease.

158 views, By Bio Data Bridges
Free assessment offered by new bio data consulting and contracting firm

124 views, By Golden Helix, Inc.
Today, Golden Helix, Inc. announced a new initiative, Golden Helix Gives Back, which provides free analytic software to academic researchers without adequate funding.

210 views, By Immune Response BioPharma, Inc.
Immune Response BioPharma, Inc. Files REMUNE Pediatric HIV/AIDS Phase II Study Protocol with the FDA for Breakthrough Designation

231 views, By NAPSRx
Abbvie has disclosed their Q3 report for 2014 and once again their breakthrough therapeutic treatment HUMIRA is leading the way in sales. Worldwide sales of HUMIRA increased 17.5 percent raking in $3.26 billion.

248 views, By Nanolive SA
Nanolive SA, a start-up company founded last year at the EPFL Innovation Park in Lausanne, Switzerland, has developed a revolutionary microscope which, for the very first time, allows the exploration of a living cell in 3D without damaging it.

319 views, By NAPSRx
The Bayer Group has released their third quarter earnings for the 2014 financial year and the company beat analysts’ expectations posting a 13% rise in third-quarter net profit.



Page:

Page updated every 10 minutes


  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
9K2K1K
Click to Share